INTERNATIONAL: Ogilvy buys Feinstein in biotech expansion
NEW YORK: Ogilvy PR Worldwide has continued its acquisition spree, buying Massachusetts-based Feinstein Kean Partners - a healthcare and biotech agency with annual fees in excess of pounds 5 million.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>